Subthalamic deep brain stimulation in Parkinson's disease with SNCA mutations: Based on the follow‐up to 10 years
Open Access
- 18 January 2022
- journal article
- research article
- Published by Wiley in Brain and Behavior
- Vol. 12 (2) , e2503
Abstract
Backgrounds: Although the short‐term efficacy of bilateral subthalamic deep brain stimulation (DBS) has been reported in a limited number of Parkinson's disease (PD) patients with SNCA mutations, there are no data for long‐term outcome.Methods: This multicenter retrospective study investigated previously reported PD patients with SNCA mutations, implanted with bilateral subthalamic DBS. We compared demographic and clinical data at baseline and last follow‐up. Clinical data of motor and nonmotor symptoms and motor fluctuation were collected up to 10 years from DBS surgery.Results: Among four subjects, three had SNCA duplication and one had c.158C.A (p.A53E) mutation. The mean post‐implantation follow‐up duration was 5.4 ± 3.7 years. All patients with SNCA duplication showed favorable outcome, although one died from breast cancer 1.5 years after DBS. The patient with the missense mutation became wheelchair‐bound due to progressed axial, cognitive and psychiatric symptoms after 3.5 years from DBS despite the benefit on motor fluctuation.Conclusion: Based on findings in our small cohort, subthalamic DBS could be beneficial for motor fluctuation in PD patients with SNCA mutations, especially those with SNCA duplication, and cognitive and psychiatric symptoms are important for the long‐term outcome of subthalamic DBS.Keywords
This publication has 13 references indexed in Scilit:
- A Meta-Analysis of α-Synuclein Multiplication in Familial ParkinsonismFrontiers in Neurology, 2018
- Genotype‐phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic reviewMovement Disorders, 2018
- Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's diseaseParkinsonism & Related Disorders, 2016
- Genetics of Parkinson's diseaseMolecular and Cellular Probes, 2016
- Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutationNeurology Genetics, 2015
- Successful GPi stimulation in genetic Parkinson’s disease caused by mosaicism of alpha-synuclein gene duplication: first descriptionJournal of Neurology, 2014
- Subthalamic Deep Brain Stimulation for a Parkinson’s Disease Patient With Duplication of SNCANeuromodulation: Technology at the Neural Interface, 2013
- Successful subthalamic stimulation in genetic Parkinson’s disease caused by duplication of the α-synuclein geneJournal of Neurology, 2011
- α-Synuclein gene duplication is present in sporadic Parkinson diseaseNeurology, 2008
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004